Revisiting the IGF-1R as a breast cancer target
Abstract The type I insulin-like growth factor-1 receptor is a well-described target in breast cancer and multiple clinical trials examining insulin-like growth factor-1 receptor have been completed. Unfortunately, monoclonal antibodies and tyrosine kinase inhibitors targeting insulin-like growth fa...
Guardado en:
Autores principales: | Roudy Chiminch Ekyalongo, Douglas Yee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff753cb1f1364c4681fe4a6c2ca7b956 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emerging targeted combinations in the management of breast cancer
por: Lee RJ, et al.
Publicado: (2013) -
Targeting γ-secretase in breast cancer
por: Han J, et al.
Publicado: (2012) -
Inhibiting breast cancer by targeting the thromboxane A2 pathway
por: Haitao Li, et al.
Publicado: (2017) -
Estrogen receptor (ER) and progesterone receptor (PgR) in breast cancer of Indian women
por: Patil AV, et al.
Publicado: (2011) -
Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Yinqi Zhang, et al.
Publicado: (2021)